SchaeferBBartosovaMMacher-GoeppingerS, et al.Neutral pH and low–glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis. Kidney Int2018; 94(2): 419–429.
2.
JohnsonDWBrownFGClarkeM, et al.balANZ Trial Investigators. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol2012; 23: 1097–1107.
3.
ChoKHDoJYParkJW, et al.The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients. Perit Dial Int2013; 33: 382–390.
4.
ChoYJohnsonDWCraigJC, et al.Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev2014; 3: CD007554.
5.
YohannaSAlkatheeriAMBrimbleSK, et al.Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis. Clin J Am Soc Nephrol2015; 10: 1380–1388.
6.
ParkSHDoJYKimYH, et al.Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study. Nephrol Dial Transplant2012; 27: 1191–1199.
7.
FanSLPileTPunzalanS, et al.Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int2008; 73: 200–206.
8.
SikanetaTWuGAbdolellM, et al.The trio trial – a randomized controlled clinical trial evaluating the effect of a biocompatible peritoneal dialysis solution on residual renal function. Perit Dial Int2016; 36: 526–532.
9.
MisraPSNessimSJPerlJ. ‘Biocompatible’ neutral pH low-GDP peritoneal dialysis solutions: Much ado about nothing?Semin Dial2017; 30(2): 164–173.
